High-dose etoposide in allogeneic stem cell transplantation

Clofarabine, cyclophosphamide and etoposide for the treatment of relapsed or resistant acute leukemia in pediatric patients

(2012) Maurizio Miano et al.   LEUKEMIA & LYMPHOMA

Chemotherapeutics and Radiation Stimulate MHC Class I Expression through Elevated Interferon-beta Signaling in Breast Cancer Cells

(2012) Shan Wan et al.   PLoS One

Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignancies

(2011) J. Magenau et al.   BLOOD

CD4+ T regulatory cells are more resistant to DNA damage compared to CD4+ T effector cells as revealed by flow cytometric analysis

(2011) Claudia Winzler et al.   CYTOMETRY PART A

Epigenetic inactivation of TWIST2 in acute lymphoblastic leukemia modulates proliferation, cell survival and chemosensitivity

(2011) S. H. Thathia et al.   HAEMATOLOGICA

Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia

(2011) Akio Shigematsu et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Sequential chemotherapy and myeloablative allogeneic hematopoietic stem cell transplantation for refractory acute lymphoblastic leukemia

(2011) Kotaro Arita et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Cancer treatment-induced oral mucositis: a critical review

(2011) A. Rodríguez-Caballero et al.   INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY

MEIS1, PREP1, and PBX4 Are Differentially Expressed in Acute Lymphoblastic Leukemia: Association of MEIS1 Expression with Higher Proliferation and Chemotherapy Resistance

(2011) Judith A Rosales-Aviña et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Phase I trial and pharmacokinetic study of high-dose clofarabine and busulfan and allogeneic stem cell transplantation in adults with high-risk and refractory acute leukemia

(2011) S S Farag et al.   LEUKEMIA

A Phase I Trial of High-Dose Clofarabine, Etoposide, and Cyclophosphamide and Autologous Peripheral Blood Stem Cell Transplantation in Patients with Primary Refractory and Relapsed and Refractory Non-Hodgkin Lymphoma

(2010) Shivani Srivastava et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Etoposide induces more severe mucositis than CY when added to TBI as conditioning in allograft recipients receiving CsA and MTX

(2010) R Hoyt et al.   BONE MARROW TRANSPLANTATION

Salvage therapy with nelarabine, etoposide, and cyclophosphamide in relapsed/refractory paediatric T-cell lymphoblastic leukaemia and lymphoma

(2010) Leah A. Commander et al.   BRITISH JOURNAL OF HAEMATOLOGY

Multiple unit umbilical cord blood transplantation with total body irradiation, etoposide and antithymocyte globulin for adult haematological malignancy patients

(2010) Ronald M. Sobecks et al.   BRITISH JOURNAL OF HAEMATOLOGY

Antineoplastic Mechanisms of Niclosamide in Acute Myelogenous Leukemia Stem Cells: Inactivation of the NF- B Pathway and Generation of Reactive Oxygen Species

(2010) Y. Jin et al.   CANCER RESEARCH

Combination of Intensive Chemotherapy and Anticancer Vaccines in the Treatment of Human Malignancies: The Hematological Experience

(2010) Knut Liseth et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Long-Term Outcome in Children With Relapsed Acute Lymphoblastic Leukemia After Time-Point and Site-of-Relapse Stratification and Intensified Short-Course Multidrug Chemotherapy: Results of Trial ALL-REZ BFM 90

(2010) Gesche Tallen et al.   JOURNAL OF CLINICAL ONCOLOGY

Pharmacokinetics of high-dose etoposide administered in combination with fractionated total-body irradiation as conditioning for allogeneic hematopoietic stem cell transplantation in children with acute lymphoblastic leukemia

(2010) Maria Chrzanowska et al.   PEDIATRIC TRANSPLANTATION

Distinct Patterns of DNA Damage Response and Apoptosis Correlate with Jak/Stat and PI3Kinase Response Profiles in Human Acute Myelogenous Leukemia

(2010) David B. Rosen et al.   PLoS One

Sequential Intensified Conditioning and Tapering of Prophylactic Immunosuppressants for Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation for Refractory Leukemia

(2009) Qi-Fa Liu et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

The Wnt signaling pathway regulates Nalm-16 b-cell precursor acute lymphoblastic leukemic cell line survival and etoposide resistance

(2009) L.S. Thiago et al.   BIOMEDICINE & PHARMACOTHERAPY

Clofarabine, cyclophosphamide and etoposide as single-course re-induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemia

(2009) Franco Locatelli et al.   BRITISH JOURNAL OF HAEMATOLOGY

Impaired S-Phase Arrest in Acute Myeloid Leukemia Cells with a FLT3 Internal Tandem Duplication Treated with Clofarabine

(2009) C. Seedhouse et al.   CLINICAL CANCER RESEARCH

A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia

(2009) N Hijiya et al.   LEUKEMIA

Excellent Outcome of Allogeneic Hematopoietic Stem Cell Transplantation Using a Conditioning Regimen with Medium-Dose VP-16, Cyclophosphamide and Total-Body Irradiation for Adult Patients with Acute Lymphoblastic Leukemia

(2008) Akio Shigematsu et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimen

(2008) G. G. Laport et al.   BLOOD

Anticancer Immunotherapy in Combination with Proapoptotic Therapy

(2008) Oystein Bruserud et al.   CURRENT CANCER DRUG TARGETS

Acute lymphoblastic leukaemia

(2008) Ching-Hon Pui et al.   LANCET

Secondary malignant neoplasms after intensive treatment of relapsed acute lymphoblastic leukaemia in childhood

(2007) Anja Borgmann et al.   EUROPEAN JOURNAL OF CANCER